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though the specific functions of sleep have not been completely
elucidated, the literature has suggested that sleep is essential for
proper homeostasis. Sleep loss is associated with changes in behav-
ioral, neurochemical, cellular, and metabolic function as well as
impaired immune response. Using high-resolution microarrays we
evaluated the gene expression profiles of healthy male volunteers who
underwent 60 h of prolonged wakefulness (PW) followed by 12 h of
sleep recovery (SR). Peripheral whole blood was collected at 8 am in
the morning before the initiation of PW (Baseline), after the second
night of PW, and one night after SR. We identified over 500 genes that
were differentially expressed. Notably, these genes were related to
DNA damage and repair and stress response, as well as diverse
immune system responses, such as natural killer pathways including
killer cell lectin-like receptors family, as well as granzymes and T-cell
receptors, which play important roles in host defense. These results
support the idea that sleep loss can lead to alterations in molecular
processes that result in perturbation of cellular immunity, induction of
inflammatory responses, and homeostatic imbalance. Moreover, ex-
pression of multiple genes was downregulated following PW and
upregulated after SR compared with PW, suggesting an attempt of the
body to re-establish internal homeostasis. In silico validation of
alterations in the expression of CETN3, DNAJC, and CEACAM genes
confirmed previous findings related to the molecular effects of sleep
deprivation. Thus, the present findings confirm that the effects of sleep
loss are not restricted to the brain and can occur intensely in peripheral
tissues.
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SLEEP CAN BE DIVIDED INTO two activity states in the mammalian
brain: nonrapid eye movement (NREM) sleep and rapid eye
moment (REM) sleep. Several roles of sleep in cellular net-
work recovery and energy conservation, endocrine system
organization, ecological and behavioral adaptations, learning,
synaptic plasticity, and, most importantly, natural synaptic
homeostasis maintenance have been hypothesized (62, 79, 86).
According to the homeostatic hypothesis, plasticity processes
during wakefulness result in an increase in synaptic connec-
tions in the brain, and, therefore, the role of sleep would be to
reduce synaptic potency to a baseline level that is energetically
controllable (79, 80, 86).
Sleep loss or deprivation is characterized by a complete
absence of sleep during a certain period of time or a shorter-
than-optimal sleep time. Chronic sleep loss is common in
industrialized societies where the most frequent causes are
those associated with contemporary lifestyle and work-related
factors (81). Lack of sleep has been shown to induce several
behavioral, neurochemical, cellular, molecular, and metabolic
alterations (2–4, 29, 81, 84). It is known that glucose level
change in metabolic syndrome and sleep deprivation has been
strongly linked to glucose intolerance and hypertension,
both associated with sleep apnea and consequently sleep
deprivation (1).
Gene expression is one of the fundamental mechanisms that
control phenotype according to the need of a specific tissue or
organ in a determined situation (72). Thus, molecular biology
and genomics tools are critical to understanding the molecular
mechanisms involved in sleep and sleep deprivation. To date,
the vast majority of the studies evaluating gene expression
changes throughout the sleep-wake cycle, prolonged wakeful-
ness (PW), and sleep recovery (SR) have been performed in
different brain regions in various animal models (16, 26, 57,
58, 88). Few studies have attempted to verify the effect of sleep
loss in human volunteers (41) and since investigations have to
be limited to measures that can be obtained from peripheral
blood, the existing results are mainly related to immunological
alterations (36).
A bidirectional interaction between the peripheral blood and
central nervous system has been demonstrated, with peripheral
lymphocytes modulating the expression of hormones, cyto-
kines, and neurotransmitters (23, 36, 55, 59, 93). Classical
evidence suggests that cytokine-to-brain communication oc-
curs via the vagus nerve and sensory signals arriving via vagal
afferents affecting cerebrocortical activity and sleep stages (12,
30). The stimulus factors can alter vagal stimulation and define
electroencephalogram synchronization or desynchronization
followed by increases or decreases in the amounts of NREM
and REM sleep (73). Indeed, perturbations of the sleep-wake
cycle have been shown to be involved in a large variety of
medical conditions, such as diabetes mellitus, cardiovascular
disease (14, 63, 65), arthritis (82), certain cancers (22, 46, 47),
and kidney dysfunction (33), and are thought to be mediated by
inflammatory molecules, as a result of pathogen recognition
and activation of inflammatory cellular pathways (98). This
suggests that the effects of sleep loss are not restricted to the
brain itself. Indeed, previous studies from our group demon-
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strated that PSD caused a significant reduction of circulating
lymphocytes (25, 95), a general decrease in all cellular subsets
of spleen, mainly T and B cells (95), as well as a decrease of
total cellularity of the bone marrow and peripheral blood and a
reduction in the absolute number of hematopoietic stem/pro-
genitor cells and colony-forming units (25). In this sense, the
evaluation of peripheral blood has been shown to represent an
attractive alternative to brain tissue analyses for gene expres-
sion studies in large-scale investigations of human volunteers
(36, 41, 42). Furthermore, this approach may provide insights
into the neuroimmunological mechanisms involved in the reg-
ulation of sleep-wake cycle.
The present study is the first evaluation of the molecular
effects of 48 h (collect point) of PW followed by a period of SR
on the peripheral whole blood gene expression profile of
healthy human volunteers. These results can help to establish
the relevance of novel genes in the regulation of sleep-wake
cycles; it can also help to identify the biological processes that
occur in a particular sleep model.
METHODS
Subjects. Subjects were nine healthy human male volunteers rang-
ing from 19 to 29 yr of age for each condition tested, summing up to
a total of 27 independent observations. The sex selection was chosen
mainly to avoid possible hormonal variations in females. In addition,
sex can influence the transcriptional profiles, and a growing body of
research has examined the modulation of brain dopaminergic systems
by estrogen. The volunteers were carefully examined by trained
physicians with the following exclusion criteria: engagement in shift
work, presence of sleep disorders, extreme morningness or evening-
ness, history of neurological or psychiatric diseases and medical
conditions, smoking, alcohol or substance abuse. These criteria were
evaluated by validated questionnaires such as Pittsburgh Sleep Qual-
ity Index, Epworth Sleepiness Scale, and the Beck Depression Inven-
tory, as well as full-night polysomnography, a sleep diary, and
actigraphy for a period of 1 wk before the protocol. Volunteers also
underwent urine analysis to detect amphetamine, methamphetamine,
cocaine, tetrahydrocannabinol, barbiturates, opiates, and benzodiaz-
epines. More details of the study protocol can be found in our previous
study (60). The study was conducted at the Sleep Laboratory of the
Department of Psychobiology at the Universidade Federal de São
Paulo and was approved by the local ethical committee (#1676/06).
All subjects signed an informed consent form.
Experimental protocol of PW. All participants were instructed
during the week preceding the study as well as during the study period
not to use alcohol, chocolate, and caffeinated beverages and to
maintain a standardized bedtime according to their common habits.
All subjects had an adaptation night followed by a night of baseline
polysomnography at the sleep laboratory. Sleep recordings were
performed on a digital electroencephalogram acquisition system with
Embla Digital A10 recording/amplifier and Somnologica software
(Flaga, Reykjavik, Iceland). The sleep deprivation period started in
the following evening after the baseline night. Thus, subjects were
kept awake for a total of 60 h (2 consecutive nights) and the following
day after the second night of PW. PW was carried out through
continuous vigilance of the volunteers by our technical staff and no
any major physical activity was allowed. In summary, the volunteers
were kept distracted reading books, watching TV, accessing the
internet, and playing video-games to help them stay awake. To be
consistent throughout the protocol, the blood collection was per-
formed in the morning, and therefore the gene expression profiles of
the PW period correspond to the time point of 48 h of wakefulness.
The volunteers were allowed to sleep at the following night after the
second night of PW (12 h SR opportunity), as summarized in Fig. 1.
The mean  SD total sleep time on the recovery night was 10:25 
00:19.
Blood collection and sample preparation for microarrays. A total
of two PAXgene tubes (PreAnalytiX, Hombrechtikon, Switzerland) of
peripheral blood from each volunteer were collected following the
baseline night and in the morning at 8 AM after 48 h of PW and after
the night of SR (following morning). After collection, the tubes were
incubated at room temperature for 2 h to allow RNA stabilization and
then stored at 80°C. RNA was extracted from whole blood with the
PAXgene Blood RNA System Kit following the manufacturer’s
recommendation. The RNA quality was evaluated by 1.0% agarose
gel, with ethidium bromide staining, and RNA concentrations were
determined with a NanoDrop ND-8000 spectrophotometer (Nano-
Drop Technologies; THERMO scientific, Wilmington, DE).
Screening 
night: PSG
B  Total period of PW
Sleep recovery night: PSG 
and blood collection in 
the following morning
 First night of PW Second night of PW: blood 
collection in the following 
morning (48 hours of PW)
Baseline night: PSG 
and blood collection 
in the following 
morning
24 hours 24 hours 12 hours







Blood collection for microarray experiments
A  Screening , adaptation 
and baseline nights







Fig. 1. Experimental design. A: screening
night polysomnography (PSG), 7 days of
sleep adaptation, and baseline night (9 h
opportunity) PSG. Blood collection was per-
formed in the morning following the baseline
PSG; this collection point is considered the
baseline temporal class. B: total period of
prolonged wakefulness (PW). Blood collec-
tion for RNA extraction was performed in
the time point of 48 h (following morning of
the 2nd night of PW). Individuals remained
awake for an additional 12 h after this col-
lection before the sleep recovery (SR) pe-
riod. C: 1 night of SR: the volunteers had the
opportunity to sleep for 12 h. Blood was
collected for microarray analyses the follow-
ing morning.
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Depletion of globin transcripts and microarray protocol. Globin
mRNA was removed using the GLOBINclear-Human kit (Ambion,
Austin, TX), following the manufacturer’s recommendations. Globin
mRNA constitutes up to 70% of whole blood mRNA and can reduce
the efficacy of the microarray assay by interfering with the detection
of less abundant gene transcripts (53, 61, 74, 85, 90, 91). RNA quality
and integrity were checked with the Agilent 2100 Bioanalyzer (Agi-
lent Technologies, Palo Alto, CA).
A total of 2 g of RNA from each subject and time point was used
to hybridize 27 independents sets of GeneChip Human Genome U133
Plus 2.0 arrays (Affymetrix, Santa Clara, CA), according to the
manufacturer’s protocol and following the best practice and high-
standard criteria required. The RNA processing and microarrays
experimental protocols were performed in the Molecular Core-Mi-
croarray Facility, São Paulo, Brazil.
Microarray data analysis. Gene expression values were obtained
using the three-step robust multiarray average preprocessing method
(37), implemented in the Affy (Affymetrix, Santa Clara, CA) package
from R/Bioconductor. The ComBat method (43) was applied prior to
analysis to correct the data for undesirable experimental variation (or
batch effect) caused by the different days in which the microarrays
were processed. ComBat implements an empirical Bayes approach,
which is commonly used in microarray analyses due to its ability
to robustly handle high-dimensional data when sample sizes are
small (43).
RankProd statistical test (10) was performed for the selection of
differentially expressed genes (DEGs) following a two-class paired
design. RankProd is a nonparametric procedure that detects genes
highly ranked in a number of lists. This rank-based feature makes the
method robust against noise and can reduce the number of replicate
experiments required to obtain reliable results (10). Furthermore, it is
an effective alternative for the identification of candidate genes in the
study of complex phenotypes, as well as when altered expression of a
given gene is expected in a subgroup of individuals due to both
multilocus genetic heterogeneity and the stochastic nature of gene
expression in multifactorial systems (11). The P value cut-off was set
at 0.01 and adjusted by use of the false discovery rate (7).
In addition, the data were analyzed by the Gene Expression
Dynamics Inspector (GEDI) method, which is based on a self-
organizing map (SOM) algorithm and creates intuitive visualization of
each sample expression profiles (19). This tool creates a map in which
each gene retains exactly the same position in the map of each sample
and permits the comparison of individual profiles based on direct
visual detection of transcriptome patterns. Inspection of GEDI maps
allows a straightforward classification of the samples into subgroups
without the aid of a clustering algorithm (19, 28). We set a 2020
SOM grid and Pearson’s Correlation of 0.01.
Functional analysis. Functional pathway, gene ontology, and net-
work analyses of the differentially expressed gene lists were per-
formed using Ingenuity Pathway Analysis (IPA) 6.3 (Ingenuity Sys-
tems, Mountain View, CA). The gene lists for the PW and SR
conditions, in relation to the baseline condition, as well as the list of
common genes between both comparisons, were mapped to its re-
spective gene object (public annotation for genes) in the Ingenuity
pathway knowledge base. These so-called focus genes were then used
as a source for creating biological networks (relationship between
genes), canonical pathways (established pathways) analysis, and bio-
logical functions. A score was assigned to each network in the dataset
to estimate the significance of the network in the selected gene list.
The IPA identifies the biological functions and/or diseases that were
most significant in the data set and right-tailed Fisher’s exact test was
used to calculate a P value determining the probability that each
biological function and/or disease assigned to that data set is due to
random chance. The most significant transcripts are then grouped into
canonical pathways. The significance of the association between the
data set and the canonical pathway was measured in two ways: 1) A
ratio of the number of molecules from the data set that map to the
pathway divided by the total number of molecules that map to the
canonical pathway is displayed; 2) a P value calculated by Fisher’s
exact test determining the probability that the association between the
genes in the dataset and the canonical pathway is explained by chance
alone.
RESULTS
Transcriptome analyses and molecular signature of PW and
SR. We performed a set of oligonucleotide microarrays con-
taining 54,675 transcripts to demonstrate the impact of sleep
loss on global gene expression levels. The Venn diagram
illustrates the intersection among the DEGs identified in the
three comparisons (Fig. 2).
Using highly stringent statistical parameters, we identified
144 DEGs in PW compared with baseline (PW  Baseline),
with the majority of 124 genes found to be downregulated after
PW (86.1%) and the remaining 20 (13.9%) were upregulated.
On the other hand, the majority of the 592 DEGs identified in
SR condition compared with PW (SR PW) were upregulated
(93.58%).The comparison between Baseline and SR condition
(SR  Baseline) revealed 135 DEGs, 121 (89.62%) of which
were upregulated and 12 (10.38%) downregulated.
A total of 78 genes were found in common among PW 
Baseline and SR  PW comparisons and may be considered
the molecular signature of the effects of sleep loss in this study
(Supplemental Table S1).1 Interestingly, all of the shared genes
show an opposite expression pattern in each comparison tested
(e.g., a particular gene might be downregulated following PW
and upregulated following SR). Conversely, the 59 common
genes identified in SR  PW and SR  Baseline comparisons
demonstrated the same directional expression pattern. A sim-
ilar trend was observed for the 22 common genes between
Baseline  PW and Baseline  SR DEGs lists, with few
exceptions such as CLEC2B, PFDN4, CD69, MALAT1,
POLR2K, and CENPK genes, which were downregulated after
PW, and upregulated following SR, in contrast to both PW and
Baseline values. Interestingly, these six genes were the only






PW x SR Baseline x SR
Fig. 2. Venn diagram. Each circle represents the number of different expressed
genes (DEGs) between 2 conditions (baseline PW  144 genes; PW  SR 
592 genes, and baseline  SR  135 genes). Each intersection contains the
number of DEGs in common among 2 or 3 of these comparisons.
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common transcripts among the three comparisons. Gene on-
tology and functional network analyses of the 78 overlapping
DEGs between the PW Baseline and SR PW comparisons
revealed a number of significantly enriched biological func-
tions and canonical pathways (Supplemental Table S1 and
Table1). Functions related to the immune response, in addition
to canonical pathways related to natural killer (NK) cell sig-
naling and cross talk between dendritic and NK cells, mito-
chondrial dysfunction, and oxidative phosphorylation, were
most enriched after PW and SR periods. In an attempt to
evaluate whether the volunteers were properly rested after one
night of SR, we examined three outcome metrics [lapses,
sleepiness before the psychomotor vigilance test (PVT), and
sleepiness after PVT] available in Table 2. The number of
lapses were significantly higher in PW (mean  13.66, SD 
11.42) than baseline (mean  0.666, SD  1.11; P  0.008),
and this number returned to baseline values after SR (mean 
0.888, SD  1.69; P  0.008 vs. PW and P  0.892 vs.
baseline). These objective measurements of sleepiness demon-
strated that the parameters were altered after PW and returned
to the baseline after one night of sleep recovery opportunity.
These data confirmed that one night of recovery was apparently
enough to re-establish cognitive functions and may support our
results, in which the majority of genes returned to baseline
expression patterns.
In addition, the period of SR activated a set of genes that was
unique to the SR  PW comparison, which resulted in the
enrichment of the following pathways: the eukaryotic initiation
factor 2-alpha (eIF2alpha) signaling, regulation of eIF4 and
p70S6K signaling, protein ubiquitination, mTOR signaling,
and neuregulin signaling.
The gene interaction network corroborated these pathways
and functions. Figure 3 illustrates the top network enriched in
PW and the interaction among the genes in that comparison. It
was observed, for example, that the immune system, protein
synthesis, metabolism, and repair system are affected during
PW as well as after SR.
To better understand these findings, we performed analyses
with the set of 78 common genes, using the GEDI tool, which
created a map for each individual in each of the three condi-
tions tested (Fig. 4). The map images revealed the specific
visual identity of each sample, serving as a molecular portrait.
The afore mentioned significant differences between baseline
and PW gene expression patterns as well as the similarity
between SR and baseline are immediately detected by visual
inspection. In addition, the GEDI maps suggested that individ-
uals 4, 6, 7, and 9 showed a more pronounced effect of the PW
(clear distinct visual pattern of the PW condition compared
Table 1. Top representative pathways identified with Ingenuity Pathway Analysis software and related genes found in PW
vs. baseline and PW vs. SR comparisons
Canonical Pathway Genes
Tumoricidal function of hepatic natural killer cells M6PR, CYCS, GZMB, SRGN
Cytotoxic T lymphocyte-mediated apoptosis of
target cells
TRD@, CYCS, GZMB
Granzyme B signaling GZMB, GZMA, CD69
Natural killer cell signaling KLRB1, KLRD1, KLRK1, KLRC3, SH2D1A, RRAS2, KLRB1, KLRD1, PIK3R1, SH2D1B
Cross talk between dendritic cells and natural killers TRD@, GZMB, CD69, KLRB1, KLRD1, KLRK1, KLRC3, IFNG
Graft vs. host disease TRD@, GZMB
Mithocondrial dynfunction ATP5J, NDUFA4, NDUFA5, COX7B, NDUFS5, NDUFB3, COX6C, CYCS, UQCRB,
COX7C, NDUFS4
Protein ubiquitination IFNG (includes EG:15978), SACS, PSMA6, UBB, PSMA3, ANAPC10, USP1, USP6,
DNAJB9, USP31, PSMC6, USP16, HSPE1, HSPA13, DNAJC1, HSPB11, PSMA4,
HSP90AA1, PSMA2, USP9Y
Granzyme A GZMA, GZMB, INF
EiF2 signaling RPL11, RPL34, RPS17/RPS17L, RPL17, PIK3R1, RPL22L1, RPS6, RPL31, RPL26, RPL23,
RPL9, RPS27L, RPL7, RPS11, EIF4E, RPL37, RPS24, RPS7, RRAS2, RPS3A, RPL36A/
hCG 1787519, RPL35
Endoplasmatic reticulum stress/chaperones DNAJC1, DNAJB9, HSPA13, DNAJC1, HSPB11, PSMA4, HSP90AA1
Regulation of eIF4 and p70S6K signaling EIF1AY, ITGB1, RPS17/RPS17L, PIK3R1, RPS6, RPS27L, RPS11, EIF4E, RPS24, RPS7,
RRAS2, RPS3A, PPP2R2B, ITGA4
Oxidative phosphorylation ATP5J, NDUFA4, NDUFA5, COX7B, NDUFS5, NDUFB3, COX6C, UQCRB, COX7C,
NDUFS4
mTOR Signaling RPS24, RPS7, RRAS2, RPS3A, DDIT4, RPS17/RPS17L, PIK3R1, PPP2R2B, RPS6,
RPS27L, RPS11, EIF4E
Neuregulin signaling HSP90AA1, MATK, ITGB1, RRAS2, PIK3R1, HSP90AA1, RPS6, CDK5R1, ITGA4
Regulation of EIf4 and p7056K signaling EIF1AY, ITGB1, RPS17/RPS17L, PIK3R1, RPS6, RPS27L, RPS11, EIF4E, RPS24, RPS7,
RRAS2, RPS3A, PPP2R2B, ITGA4
The canonical pathways and correspondent genes that had the lowest P values from the Ingenuity Pathway Analysis 5.0. PW, prolonged wakefulness; SR, sleep
recovery.




Pn Mean SD Mean SD Mean SD
Lapses 9 0.67 1.12 13.67 11.42 0.89 1.69 0.001a
Sleepniness before PVT 9 2.22 1.20 7.11 2.98 3.67 2.12 0.002b
Sleepniness after PVT 9 2.11 1.27 8.67 1.58 3.78 1.86 0.001c
aFriedman test. Significant differences between baseline vs. PW (P 0.008)
and PW vs. SR (P  0.008); brepeated-measures ANOVA with Bonferroni
post hoc test. Significant differences between baseline vs. SR (P  0.004);
cFriedman test. Significant differences between baseline vs. PW (P  0.007),
baseline vs. SR (P  0.017), and PW vs. SR (P  0.007). PVT, psychomotor
vigilance test. SD   SD.
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with baseline), whereas individuals 1 2, 3, 5, and 8 demon-
strated a less pronounced effect of PW (similar visual pattern
between PW and baseline). The results corroborate with the
well-known interindividual variability in response to sleep
deprivation.
DISCUSSION
The present study used microarrays to examine the molec-
ular signatures associated with sleep deprivation and recovery.
The study of global gene expression by microarrays has been
shown to be useful in identifying candidate genes and associ-
ated molecular pathways in a variety of complex phenotypes
(5, 6, 15, 27, 56–58, 72). Indeed, the literature is populated
with extensive data about the molecular effects of sleep-related
states in different brain regions of animal models (15, 58, 64,
88). However, in humans, due to technical limitations in
assessing brain tissue, the evaluation of peripheral total blood
or specific cell lines has emerged as an interesting and readily
available source for studying gene expression profiles (64).
Several differentially expressed genes were recognized to be
related to the immune system, cell death, protein processes,
endoplasmatic reticulum (ER), and homeostasis in whole blood
of volunteers subjected to a protocol consisting of PW and SR
periods. Likewise, we explored several relevant genetic path-
ways. The majority of the differentially regulated genes were
grouped into specific inflammatory regulation and immune
system pathways following PW, which corroborates previous
findings reported by our group on the immune effects of sleep
deprivation (25, 75, 76, 95). More specifically, after 60 h of
PW, we detected the downregulation of several genes involved
in NK-like receptors repertory and in the cross talk between
NK cells and dendritic cell response. The NK family is known
to play a role in mediating natural resistance against tumors
and infections (87), while the cross talk between NK cells and
dendritic cells is required for optimal immune cell expansion,
activation of proinflammatory cytokines, and stimulation of
T-cell responses (89). In addition, the gene that encodes a














































Fig. 3. Connectivity map of interactions among genes differently expressed after 48 h of PW. The downregulated genes observed after the PW period are indicated
in green, and the upregulated indicated in red. The blank symbols pertain to genes that were either not present in the GeneChip Human Genome U133 Plus 2.0
array or not differentially expressed. Solid blue lines indicate a direct linkage among the genes and their classification. Networks are related to the immune system,
protein synthesis, metabolism, and repair system were affected during PW compared with baseline. Maps were constructed with Ingenuity Pathway Analysis
(IPA).
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ognizing antigens bounded to major histocompatibility com-
plex, was also downregulated after PW, followed by a signif-
icant upregulation after SR.
Consistent with these findings, other groups have previously
reported increased disease susceptibility, as a result of reduced
immune system response, accompanied by a decline of cellular
immunity molecules, such as NK receptors (20, 40, 77, 92).
Moreover, increased T-cell activity and a 30% lower NK count
in the blood were demonstrated in people sleeping 7 h
compared with a regular night’s sleep (7–9 h) in a study
evaluating the effects of short natural sleep time on both T-cell
receptors and NK repertory (20). Additionally, studies ex-
amining host resistance to viral infection and vaccine re-
sponses have also linked lack of sleep and immunological
alterations (8, 9, 18, 39, 51, 75). Spiegel et al. (78) showed
that volunteers whose sleep was restricted to 4 h a night for
six nights had less than half the immune response when
vaccinated for influenza compared with the controls who had
not been sleep deprived. Additionally, Irwin et al. (41) dem-
onstrated that only one night (11 PM–3 AM) of restricted sleep
significantly reduced white blood cell activity and induction of
inflammatory molecules. Together with our data, these findings
support the concept that adequate amounts of sleep are neces-
sary to preserve the immune responses. In addition, the slight
increase in expression of the TCR delta and NK-like receptors
pathways during SR in our subjects and the inversion of the global
gene expression pattern between PW and SR may indicate the
body’s attempt to re-establish the basal activity of these molecules
and, consequently, the homeostatic equilibrium.
Additionally, the pathway analysis also revealed interesting
results in the unique genes altered after SR process, compared
with PW. The following pathways were most enriched in this
analysis: eIF2alpha signaling, regulation of eIF4 and p70S6K
signaling, protein ubiquitination, mTOR signaling, and neu-
regulin signaling. The eIF2alpha signaling pathway is associ-
ated with molecular signals that designate activation of the
unfolded protein response (UPR) pathway, as a result of the
accumulation of misfolded proteins in the ER (67, 70, 71, 97).
The UPR inhibits protein shipment by upregulating the expres-
sion of ER chaperones such as binding immunoglobulin pro-
tein and glucose-regulated protein 78, as well as attenuating
protein translation through the phosphorylation of eIF2alpha
(70, 71). This pathway was already correlated to the protection
of brainstem motoneurons in a murine model of intermittent
hypoxia present in sleep apnea events (97), which corroborates
the findings in our data. Additionally, we found that the
conserved serine/threonine kinase mTOR (the mammalian tar-
get of rapamycin) activates S6K1 and 4EBP1, which are
involved in mRNA translation. The mTOR signaling pathway
is activated by diverse stimuli, such as growth factors, nutri-
ents, and energy and stress signals, and it was previously
associated to hypoxia and sleep (94). The neuregulin signaling
pathway has been implicated in neurodevelopmental processes
such as myelination and neuronal migration, as well as in the
development of schizophrenia (13). Although this specific
pathway has not been associated with sleep-related pheno-
types, the importance of these genes in brain and neuronal
plasticity (54) suggests a possible role of the neuregulin sig-
naling pathway in sleep homeostasis.
Moreover, our in silico validation of centrin-3 (CETN3),
DnaJ (Hsp40), homolog C (DNAJC), and carcinoembryonic
antigen-related cell adhesion molecule (CEACAM) genes con-
firmed other findings evaluating the molecular effects of sleep
deprivation, sleep apnea, and ER stress processes involving
protein folding (38, 45, 55–58). The CETN3 gene encodes a
member of the centrin protein family. Transcript level changes
of the CETN3 gene were demonstrated between wakefulness
and sleep in a study evaluating a quantitative trait locus (QTL)
previously identified as a genomic region on chromosome 13.




ID1 ID2 ID3 ID4 ID5 ID6 ID7 ID8 ID9
Fig. 4. Gene Expression Dynamics Inspector (GEDI) output results. The method is based on a self-organizing map (SOM) algorithm and creates visualization
of each sample expression profiles. Each GEDI map displays the expression pattern of 78 genes, serving as a molecular portrait for each individual (ID) in each
of the 3 conditions tested (baseline, PW, and SR). The blue color represents the lowest expression level, and red color represents the highest expression level
respectively. The maps exhibited significant differences among baseline and PW expression patterns as well as the similarity among baseline and SR.
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(or Dps1) (21, 56). In this sense, although the role of the
CETN3 gene in sleep remains to be elucidated, its location in
a potential regulatory region of sleep homeostasis and the fact
that this gene was identified as differentially expressed after
sleep deprivation in two independent studies suggest that this
finding deserves further evaluation. In the same line, the
upregulation of DNAJC1 gene, a member of the heat shock
family of proteins, which acts in the ER and is responsible for
protein folding and molecular chaperone functions, has been
previously identified as differentially expressed in cerebral
cortex of mice and rats during wakefulness (56, 66–69).
Accordingly, previous studies have consistently demonstrated
that PW leads to perturbations that alter ER homeostasis
(66–69). These alterations therefore disturb protein folding
and lead to an increase in unfolded proteins and protein
aggregates, which are detrimental to cell survival (66–69). As
an escape process, the cell attempts to adapt, promoting a
synchronized response to limit accumulation of unfolded pro-
teins in the ER, which corroborates with the upregulation of
heat shock proteins after a period of sleep loss found in the
present study. It is worthwhile to mention that this alternative
mechanism of stress is not cortisol-related. Indeed, our study
supports this idea since the subjects’ cortisol level measure-
ments did not increase following PW (60).
Finally, CEACAM family genes have already been associ-
ated with sleep phenotypes in a previous study (45), which
serves as a further in silico validation of our findings. Khalyfa
et al. (45) demonstrated that members of the CEACAM family,
such as CEACAM1, CEACAM5, and CEACAM6, were upregu-
lated in tonsillar tissues from sleep apnea patients with adeno-
tonsillar hypertrophy, and proposed this gene family as a
potential candidate in the molecular mechanisms underlying
this sleep disorder.
Although sleep deprivation itself is distinct from obstructive
sleep apnea (OSA), they have a myriad of overlapping effects
in common such as metabolic alterations, oxidative stress,
inflammation, and perturbation of immune system, as demon-
strated by previous studies (35, 41, 44). In addition, shared
molecular capacities such as sympathetic activation, oxidative
stress, and inflammation are affected in both situations, and,
therefore, it is reasonable to think that common genes may be
influenced as a result of OSA and sleep deprivation. However,
it is important to mention that, despite the overlapping effects,
OSA presents independent mechanisms for causing sleep frag-
mentation and therefore differs from isolated sleep deprivation.
CEACAMs are part of a group of mammalian immunoglobu-
lin-related glycoproteins. They are involved in cell recognition,
modulation of tissue architecture, regulation of T-cell prolifer-
ation, and a pivotal key marker in cancer progression (48). In
the present study, the upregulation of CEACAM6 and 8 was
observed after PW and remained altered following the SR
period. Structurally, both proteins share close homology and
functionality and have been implicated in cell adhesion, met-
astatic behavior of tumor cells such as leukemia and gastric
cancer, and bone marrow disorder such as myelofibrosis (31,
52, 96). Taken together, these findings imply a potential link
between shorter sleep duration and increased risk of develop-
ing different types of cancer (32, 48).
To be considered a sleep regulatory substance, a number of
criteria should be met (17), and, to date, only interleukin 1,
tumor necrosis factor, growth hormone releasing hormone,
prolactin, and nitric oxide have been described as having all the
required characteristics. In this sense, it is important to note
that we cannot affirm that the genes identified in this study are
real regulatory markers, rather that the findings of the present
study provide an overview of the direct effects of sleep loss on
the gene expression profile of a peripheral tissue and of the
potential biological markers and pathways, which should be
validated in further studies.
The graphs generated by the GEDI program illustrated the
differences between the global expression pattern of individu-
als in baseline and PW conditions and the similarity between
SR and baseline conditions. They also showed different indi-
vidual responses for a similar condition tested, an effect we
expected since sleep deprivation is a complex process and
known to affect individuals differently (24, 83). It has been
demonstrated that there are considerable individual differences
in cognitive performance deficits resulting from shift work
schedules as well in sleep electroencephalography (EEG) read-
ings (49, 50). Evidence suggests that individual sleep EEG
patterns in NREM sleep and REM sleep are heritable traits. As
an example, multiple recordings in the same individuals, as
well as studies in monozygotic and dizygotic twins, suggest
that a very high percentage of the robust interindividual vari-
ation and the high intraindividual stability of sleep EEG pro-
files can be associated with genetic factors (90% in distinct
frequency bands) (49, 50). The molecular mechanisms of
interindividual variation are essentially unknown, and the ge-
netics and gene expression studies of normal sleep and SD are
only beginning to be elucidated.
Sleep is important for repair in the brain and macromolecule
biosynthesis, as well as for activities in peripheral tissue, such
as the ones related to immune system regulation. Changes in
gene expression between sleep and wakefulness, as revealed by
different microarrays studies, have led us to a new understand-
ing of the functions of sleep that will likely be the focus of
future research in neuroscience. Nevertheless, we believe that
sleep and SD can affect distinct peripheral tissues and are not
restricted to the brain, as previously suggested (34).
Due to the low amounts of RNA obtained from blood tissue
after the globin reduction treatment, an important limitation of
this study is the lack of validation of the findings with an
independent technique. Nevertheless, a total of 78 genes were
found in common between the Baseline  PW and PW  SR
comparisons. The fact that these genes were identified in two
independent analyses and were significantly expressed in op-
posite directions may be seen as a cross-validation of the
presented findings. Moreover, in silico validation was provided
for CETN3, DNAJ1, and CEACAM genes. Finally, in attempt to
reduce the false-positive findings rate, we choose robust sta-
tistical analysis methods to establish the DEGs with stringent
statistical correction. In this sense, it is clear that additional
studies will be necessary to fully validate the potential candi-
date genes and functional network identified. However, the
present results should open new frontiers regarding the evalu-
ation of gene expression profiles in sleep medicine, as well as
motivate further investigations to define the molecular effects
of PW in humans.
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